MLANA and melanoma: We selected for the present in vitro study a 25-mer sequence of the Melan-A/MART-1 melanoma associated antigen bearing an anchor optimized analog of the immunodominant CD8+ epitope (epitope of Melan-A: Melan-A26–35 A27L on HLA-A2) [22].